Alzheimer's and dementia drug development and clinical companies
For reference only. Not investment advice. You are solely responsible for your investment decisions.
6/24 · Real-time
No losers
Of 5 Alzheimer's Treatment stocks tracked today, 5 are up and 0 down (avg +4.09%), an overall strongly higher tone. The top gainer is 알테오젠 (+7.21%), while 클래시스 (+1.94%) lags the group.
Based on live prices and updated periodically. Not investment advice.
Alzheimer's and dementia drug development and clinical companies Switch between Korean and US stock tabs below to see live prices.
Based on publicly known business structure. Not investment advice.
Alzheimer's Treatment Stocks is a key investment theme in 2026. Alzheimer's and dementia drug development and clinical companies PFlow tracks 13 related stocks — 6 Korean and 7 US — with live prices in one view.
There are 13 stocks related to Alzheimer's Treatment Stocks — 6 Korean and 7 US stocks. Check live prices and performance in the tabs above.
PFlow's Alzheimer's Treatment Stocks page (pflow.app/en/theme/alzheimer) shows Korean and US leading stocks with live price changes. Click any stock to view detailed data.
Korean Alzheimer's Treatment Stocks stocks are 6 KOSPI/KOSDAQ-listed companies, while US Alzheimer's Treatment Stocks stocks are 7 NASDAQ/NYSE-listed companies. Comparing both helps gauge global demand trends and valuation differences.
There are 13 companies related to Alzheimer's Treatment — 6 Korean and 7 US. Check their live prices and leading stocks in the list above.
※ This page provides price information for companies with business connections to the listed theme. It is not a recommendation to buy or sell any specific stock. Investors are solely responsible for their investment decisions. Please conduct thorough research before investing.